We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.51%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$28.5B
AUM Growth
+$2.42B
(+9.3%)
Cap. Flow
+$581M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
1,921
New
171
Increased
1,320
Reduced
356
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
VF Corp
VFC
|
+$73.4M |
| 3 |
Amazon
AMZN
|
+$71M |
| 4 |
Stanley Black & Decker
SWK
|
+$60.2M |
| 5 |
Tesla
TSLA
|
+$46.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$158M |
| 2 |
Apple
AAPL
|
+$130M |
| 3 |
Cardinal Health
CAH
|
+$43.7M |
| 4 |
Fortinet
FTNT
|
+$39.6M |
| 5 |
ExxonMobil
XOM
|
+$32.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.73% |
| 2 | Industrials | 12.07% |
| 3 | Consumer Staples | 11.64% |
| 4 | Healthcare | 11.12% |
| 5 | Financials | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Acadia Pharmaceuticals
ACAD
$4.25B
| $459K | ﹤0.01% |
28,862
+1,993
| +7% | +$31.2K |
|
1002
Valmont Industries
VMI
$9.44B
| $459K | ﹤0.01% |
1,387
+161
| +13% | +$51.1K |
|
1003
Encompass Health
EHC
$11.2B
| $458K | ﹤0.01% |
7,658
+618
| +9% | +$33.6K |
|
|
AKRO
1004
DELISTED
Akero Therapeutics
AKRO
| $458K | ﹤0.01% |
8,353
+2,104
| +34% | +$90.1K |
|
1005
Viavi Solutions
VIAV
$9.75B
| $457K | ﹤0.01% |
43,446
+3,746
| +9% | +$45.1K |
|
1006
Unifirst Corp
UNF
$5.32B
| $457K | ﹤0.01% |
2,366
+305
| +15% | +$55.8K |
|
|
JBTM
1007
JBT Marel
JBTM
$7.14B
| $457K | ﹤0.01% |
4,999
+644
| +15% | +$58.9K |
|
1008
Coca-Cola Consolidated
COKE
$12.3B
| $454K | ﹤0.01% |
8,860
+1,140
| +15% | +$54.5K |
|
1009
Snap
SNAP
$7.32B
| $451K | ﹤0.01% |
50,423
-297
| -0.6% | -$2.93K |
|
1010
BioCryst Pharmaceuticals
BCRX
$2.37B
| $451K | ﹤0.01% |
39,285
+3,202
| +9% | +$39.9K |
|
1011
Shoals Technologies Group
SHLS
$1.58B
| $450K | ﹤0.01% |
18,257
+5,635
| +45% | +$136K |
|
1012
Roku
ROKU
$21.1B
| $450K | ﹤0.01% |
11,056
+3,443
| +45% | +$180K |
|
1013
Plexus
PLXS
$6.81B
| $447K | ﹤0.01% |
4,340
+558
| +15% | +$56.4K |
|
1014
Innovative Industrial Properties
IIPR
$1.78B
| $445K | ﹤0.01% |
4,390
+566
| +15% | +$60.3K |
|
1015
Forward Air
FWRD
$482M
| $444K | ﹤0.01% |
4,235
+541
| +15% | +$56.8K |
|
1016
Supernus Pharmaceuticals
SUPN
$2.68B
| $443K | ﹤0.01% |
12,429
+1,068
| +9% | +$37.1K |
|
|
SAGE
1017
DELISTED
Sage Therapeutics
SAGE
| $443K | ﹤0.01% |
11,624
+882
| +8% | +$33.7K |
|
1018
Bloom Energy
BE
$52.6B
| $443K | ﹤0.01% |
23,149
+3,761
| +19% | +$73.9K |
|
1019
Churchill Downs
CHDN
$6.03B
| $442K | ﹤0.01% |
4,184
+422
| +11% | +$44.5K |
|
1020
Amylyx Pharmaceuticals
AMLX
$2.05B
| $442K | ﹤0.01% |
+11,968
| New | +$425K |
|
1021
Globus Medical
GMED
$10.4B
| $441K | ﹤0.01% |
5,942
+505
| +9% | +$34.4K |
|
|
COOP
1022
DELISTED
Mr. Cooper
COOP
| $441K | ﹤0.01% |
10,978
+1,269
| +13% | +$53.6K |
|
1023
Federal Signal
FSS
$7.25B
| $439K | ﹤0.01% |
9,455
+1,220
| +15% | +$56K |
|
|
AAWW
1024
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $439K | ﹤0.01% |
4,357
+566
| +15% | +$56.7K |
|
1025
WSFS Financial
WSFS
$4.1B
| $439K | ﹤0.01% |
9,681
+983
| +11% | +$46.2K |
|
Similar funds
ProShare Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, ProShare Advisors held 1,921 positions worth $28.5B, up 9.3% from $26.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ProShare Advisors's Q4 2022 filing shows 171 new, 1,320 increased, 356 reduced and 71 closed positions. Its largest new stake was Rivian: 689,839 shares worth $12.7M. The largest sale was Target, an estimated $158M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q4 2022 buy was Rivian: 689,839 shares worth $12.7M.
- ProShare Advisors added most to Microsoft in Q4 2022, an estimated $111M increase.
- ProShare Advisors's biggest Q4 2022 reduction was Apple, cutting an estimated $130M.
- ProShare Advisors fully exited Target in Q4 2022, selling an estimated $158M.
- ProShare Advisors's ten largest holdings make up 20% of its $28.5B portfolio in Q4 2022.
- ProShare Advisors opened 171 new positions and closed 71 in Q4 2022.
- ProShare Advisors's portfolio value rose 9.3% quarter-over-quarter to $28.5B.
Based on ProShare Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.